Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 1 syndrome is an autosomal anomaly characterized by variable clinical features, most commonly including significant intrauterine and postnatal growth failure, developmental delay, intellectual disability, microcephaly, and dysmorphic facial features. Some less frequent clinical features are dysgenesis of corpus callosum, atrial septal defect, rocker bottom feet and clinodactyly.
Features include very common findings: Microcephaly, Round face, Long philtrum, and Wide nasal bridge and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 2 | Microcephaly, Round face |
Eyes |
Biomarker and diagnostic research for ring chromosome 1 has been reported in the published literature.
Phenotype severity distribution: 13 very common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 1.
122 publications have been identified in PubMed for ring chromosome 1. Research spans Basic Science / Preclinical (60%), Epidemiology / Natural History (17%), and Review / Meta-Analysis (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 73 | 60% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
1
Ptosis |
Arms and legs | 1 | Clinodactyly of the 5th finger |
Digestive system | 1 | Feeding difficulties in infancy |
Brain and nerves | 1 | Difficulty with thinking and memory (cognitive impairment) |
21 |
17% |
Research summaries | 10 | 8% |
Clinical study results | 6 | 5% |
Testing and diagnosis research | 4 | 3% |
New treatment approaches | 4 | 3% |
Patient case studies | 3 | 2% |
Lahu A (2026). [PMID: 41346087](https://pubmed.ncbi.nlm.nih.gov/41346087/). *Angew Chem Int Ed Engl*. [Basic Science / Preclinical]
Kaur S (2026). [PMID: 41360559](https://pubmed.ncbi.nlm.nih.gov/41360559/). *Food Res Int*. [Basic Science / Preclinical]
Zhang K (2026). [PMID: 41702240](https://pubmed.ncbi.nlm.nih.gov/41702240/). *Water Res*. [Basic Science / Preclinical]
Kickuth A (2026). [PMID: 41501469](https://pubmed.ncbi.nlm.nih.gov/41501469/). *Nature*. [Basic Science / Preclinical]
Cukurova F (2026). [PMID: 42199324](https://pubmed.ncbi.nlm.nih.gov/42199324/). *Clin Ophthalmol*. [Diagnostic / Biomarker]
Xu X (2026). [PMID: 41454433](https://pubmed.ncbi.nlm.nih.gov/41454433/). *Inorg Chem*. [Basic Science / Preclinical]
Schatz D (2026). [PMID: 41340291](https://pubmed.ncbi.nlm.nih.gov/41340291/). *Angew Chem Int Ed Engl*. [Basic Science / Preclinical]
Berghaus A (2026). [PMID: 41686211](https://pubmed.ncbi.nlm.nih.gov/41686211/). *HNO*. [Review / Meta-Analysis]
Alnajjar MA (2026). [PMID: 41388792](https://pubmed.ncbi.nlm.nih.gov/41388792/). *Angew Chem Int Ed Engl*. [Basic Science / Preclinical]
Alleva N (2026). [PMID: 41388103](https://pubmed.ncbi.nlm.nih.gov/41388103/). *Small*. [Review / Meta-Analysis]